Testing Effects of Glatiramer Acetate and Fingolimod in an Infectious Model of CNS Immune Surveillance

Journal of Neuroimmunology - Netherlands
doi 10.1016/j.jneuroim.2014.08.624
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Connectivity of Rapid-Testing Diagnostics and Surveillance of Infectious Diseases

Bulletin of the World Health Organization
EnvironmentalPublic HealthOccupational Health
2019English

Glatiramer Acetate Stimulates Regulatory B Cell Functions

Journal of Immunology
AllergyImmunology
2019English

Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2011English

Beta Interferons and Glatiramer Acetate for Treatment of MS: TA Guidance 2018

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2018English

Clinical Utility of Glatiramer Acetate in the Management of Relapse Frequency in Multiple Sclerosis

Journal of Central Nervous System Disease
2012English

Neuroprotection With Glatiramer Acetate: Evidence From the PreCISe Trial

Journal of Neurology
Neurology
2013English

Dual Dose-Dependent Effects of Fingolimod in a Mouse Model of Alzheimer’s Disease

Scientific Reports
Multidisciplinary
2019English

Demyelination Arrest and Remyelination Induced by Glatiramer Acetate Treatment of Experimental Autoimmune Encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Satellite Imaging and Surveillance of Infectious Diseases

Journal of Tropical Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy